EP3256154
Lyfjasamsetning sem inniheldur mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.2.2016EP published:
2.10.2019EP application number:
16703297.8
EP translation filed:
16.12.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
4.2.2036Expiry date:
4.2.2027Next due date:
28.2.2027
Title:
PHARMACEUTICAL FORMULATION COMPRISING ANTIBODY
Timeline
Today
5.2.2016EP application
2.10.2019EP Publication
16.12.2019Translation submitted
15.1.2020Registration published
4.2.2027Expires
Owner
Name:
UCB Biopharma SRLAddress:
Allé de la Recherche 60, 1070 Brussels, BE
Inventor
Name:
BOONEN, Michael Joseph EdouardAddress:
Brussels, BE
Name:
PEERBOOM, ClaudeAddress:
Brussels, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
15154301Date:
9.2.2015Country:
EP
Classification
Categories:
A61K 9/00, A61K 9/08, A61K 47/26, A61K 39/395, C07K 16/28, A61K 47/12, A61K 47/18
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 14.1.2020
Expires: 4.2.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 12.1.2021
Expires: 4.2.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 5.1.2022
Expires: 4.2.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.1.2023
Expires: 4.2.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.1.2023
Expires: 4.2.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 9.1.2024
Expires: 4.2.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 16.1.2025
Expires: 4.2.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 4.2.2026
Expires: 4.2.2027
Payer: Árnason Faktor ehf.